Home
News
Create
Screeners
Insights
Kobo Biotech
3.
76
+0.17
(+4.74%)
Market Cap
₹9.01 Cr
PE Ratio
-1.70
Industry
Chemicals
Buy
Sell
Company Performance:
1D
+4.74%
1M
+31.93%
6M
+40.30%
1Y
+34.29%
5Y
-38.36%
View Company Insights
Latest news about Kobo Biotech
NCLT Approves Beaufond Industries' Resolution Plan for Kobo Biotech Limited
May 13, 2026
The NCLT Hyderabad Bench approved the resolution plan of Beaufond Industries Limited for Kobo Biotech Limited on May 11, 2026, with a total resolution amount of INR 70.11 crores. Financial creditors are to receive INR 67.78 crores as part of the upfront payment, along with an equity upside of approximately 3% of total shareholding. The approved composite scheme involves amalgamation and demerger, resulting in a post-resolution total share capital of 3,93,47,700 shares at a face value of Rs. 10 each, with promoter shareholding at 57.23%. All pre-existing liabilities of the Corporate Debtor shall stand extinguished upon implementation of the plan.
Kobo Biotech Limited Submits SEBI Compliance Certificate for Quarter Ended March 31, 2026
Apr 15, 2026
Kobo Biotech Limited Confirms Non-Large Corporate Status Under SEBI Framework
Apr 15, 2026
Kobo Biotech Limited's Committee of Creditors Approves Multiple Resolutions, Including CIRP Extension and Professional Fees
Oct 31, 2025
Kobo Biotech's Committee of Creditors Approves 90-Day Extension for Insolvency Resolution Process
Oct 31, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar